Previous Section
Clinical Trials
31. Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer.
- Author
- Belani CP; Ramalingam S; Perry MC; LaRocca RV; Rinaldi D; Gable PS; Tester WJ;
- Institution
- Penn State Cancer Institute, H072, 500 University Drive, PO Box 850, Hershey, PA 77030, USA. cbelani@psu.edu
- Journal
- J Clin Oncol. 2008 Jan 20;26(3):468-73.
- Abstract URL
- Click here to view abstract
32. Phase I/II trial of weekly intravenous 130-nm albumin-bound paclitaxel as initial chemotherapy in patients with stage IV non-small-cell lung cancer.
- Author
- Rizvi NA; Riely GJ; Azzoli CG; Miller VA; Ng KK; Fiore J; Chia G; Brower M; Heelan R; Hawkins MJ; Kris MG;
- Institution
- Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA. rizvin@mskcc.org
- Journal
- J Clin Oncol. 2008 Feb 1;26(4):639-43.
- Abstract URL
- Click here to view abstract
33. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.
- Author
- Kunitoh H; Kato H; Tsuboi M; Shibata T; Asamura H; Ichonose Y; Katakami N; Nagai K; Mitsudomi T; Matsumura A; Nakagawa K; Tada H; Saijo N;
- Institution
- Department of Medical Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. hkkunito@ncc.go.jp
- Journal
- J Clin Oncol. 2008 Feb 1;26(4):644-9.
- Abstract URL
- Click here to view abstract
34. Randomized phase II study of gemcitabine plus cisplatin, with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
- Author
- Butts CA; Bodkin D; Middleman EL; Englund CW; Ellison D; Alam Y; Kreisman H; Graze P; Maher J; Ross HJ; Ellis PM; McNulty W; Kaplan E; Pautret V; Weber MR; Shepherd FA;
- Institution
- Cross Cancer Institute, 11560 University Ave, Edmonton, Alberta, Canada. charlesb@cancerboard.ab.ca
- Journal
- J Clin Oncol. 2007 Dec 20;25(36):5777-84.
- Abstract URL
- Click here to view abstract
35. Quality of life and survival in the 2 years after surgery for non small-cell lung cancer.
- Author
- Kenny PM; King MT; Viney RC; Boyer MJ; Pollicino CA; McLean JM; Fulham MJ; McCaughan BC;
- Institution
- Centre for Health Economics Research and Evaluation, University of Technology, Sydney, PO Box 123, Broadway, Sydney, New South Wales 2007, Australia.: patsy.kenny@chere.uts.edu.au
- Journal
- J Clin Oncol. 2008 Jan 10;26(2):233-41. Epub 2007 Dec 17.
- Abstract URL
- Click here to view abstract
36. Phase II randomized study of weekly docetaxel alone or plus UFUR treatment in non-small cell lung cancer patients who failed previous chemotherapy.
- Author
- Chou KT; Chen YM; Shih JF; Perng RP; Tsai CM; Whang-Peng J;
- Institution
- Chest Department, Taipei Veterans General Hospital, Taipei, Taiwan.
- Journal
- Lung Cancer. 2008 Jan;59(1):64-8. Epub 2007 Aug 30.
- Abstract URL
- Click here to view abstract
37. Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced non-small cell lung cancer: a randomized, multicenter phase III trial.
- Author
- Georgoulias V; Androulakis N; Kotsakis A; Hatzidaki D; Syrigos K; Polyzos A; Agelidou A; Varthalitis I; Ziras N; Agelidou M; Chandrinos V; Boukovinas I; Geroyianni A; Vamvakas L; Mavroudis D;
- Institution
- The Hellenic Oncology Research Group (HORG), Athens, Greece. georgsec@med.uoc.gr
- Journal
- Lung Cancer. 2008 Jan;59(1):57-63. Epub 2007 Aug 31.
- Abstract URL
- Click here to view abstract
38. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer.
- Author
- Kim DW; Kim SY; Kim HK; Kim SW; Shin SW; Kim JS; Park K; Lee MY; Heo DS;
- Institution
- Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
- Journal
- Ann Oncol. 2007 Dec;18(12):2009-14. Epub 2007 Sep 4.
- Abstract URL
- Click here to view abstract
39. Increasing tumor volume is predictive of poor overall and progression-free survival: secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer.
- Author
- Werner-Wasik M; Swann RS; Bradley J; Graham M; Emami B; Purdy J; Sause W;
- Institution
- Department of Radiation Oncology, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, USA. maria.werner-wasik@jeffersonhospital.org
- Journal
- Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):385-90. Epub 2007 Sep 14.
- Abstract URL
- Click here to view abstract
40. Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group.
- Author
- Kosmidis PA; Kalofonos HP; Christodoulou C; Syrigos K; Makatsoris T; Skarlos D; Bakogiannis C; Nicolaides C; Bafaloukos D; Bamias A; Samantas E; Xiros N; Boukovinas I; Fountzilas G; Dimopoulos MA;
- Institution
- Department of Medical Oncology, Hygeia Hospital, Athens, Greece. parkosmi@otenet.gr
- Journal
- Ann Oncol. 2008 Jan;19(1):115-22. Epub 2007 Oct 15.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
